Skip to main content
OpenTrials
Completed

NCT Number: NCT03331497

Tonsillotomy or Follow-up in PFAPA Syndrome

Children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) -syndrome diagnosis will be randomised either to tonsillotomy (partial tonsillectomy) or 3 months follow up. At follow up visit 3 months after randomisation the children from either groups with ongoing symptoms will be sent to tonsillectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oulu Unversity Hospital, Oulu, Finland

Loading trial locations.

About this study

Children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) -syndrome diagnosis will be randomised either to tonsillotomy (partial tonsillectomy) or 3 months follow up.

In both groups the symptoms are monitored with symptom diaries. At follow up visit 3 months after randomisation the children from either groups with ongoing symptoms will be sent to tonsillectomy (total remove of palatine tonsil).

The design is sequential trial. From the previous trials we know that the effect of tonsillectomy is about 90% and that during follow up for six months as much as 50% of the patients will recover. Because the syndrome is rare and because the rescue operations of the tonsils (tonsillectomy in a person who has gone through tonsillotomy), the sample size has to be as low as possible. That is the reason why we chose sequential design, with assessments after every 8 patient.

Randomization is made in blocks of four. In sequential design we use the following assumptions:

  • We are looking for a 40% absolute difference in cure rate between tonsillotomy (90%) and follow up (50%) groups.
  • Two sided Whitehead design
  • Maximum likelihood estimation (MLE)
  • Five assessments (sample size 4+4, 8+8. 12+12, 16+16 and 19+19)
  • type 1 error 5 % and power 80%
  • The sample size will be from 8 to 38 patients depending on when the trial can be stopped along assessments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed PFAPA syndrome: regularly occurring fever episodes for 3-5 days for at least five times or for 6 months

Exclusion criteria

  • prior tonsil surgery

Treatment and study plan

Tonsillotomy

Procedure

About 2/3 of the palatine tonsil tissue is removed with coplator or bipolar knife.

Primary outcomes

  1. Cure

    Time frame: 3 months from randomization

    Proportion of patients who do not have any PFAPA symptoms

Secondary outcomes

  1. Rescue surgery

    Time frame: 12 months from randomization

    Proportion of patients needing rescue surgery (tonsillectomy)

  2. Days with fever

    Time frame: 3 months from randomization

    Number of days with fever >38C in symptom diaries

  3. Cure

    Time frame: 6 months from randomization

    Proportion of patients who do not have any PFAPA symptoms

Sponsors and collaborators

Lead sponsor

University of Oulu

Other

Collaborators

  • Oulu University Hospital
  • Tampere University
  • Tampere University Hospital
  • Turku University Hospital
  • University of Turku

Registry information

Official study title

Tonsillotomy or Follow-up in PFAPA -Syndrome - Randomised, Controlled Study Using Sequential Design

Important dates

Study start
2017
Primary completion
2021
Study completion
2022
First posted
Nov 6, 2017
Registry last updated
Feb 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.